67 related articles for article (PubMed ID: 533219)
1. Vaginal smear history in patients with invasive cervical carcinoma.
Grundsell H; Johnsson JE; Lindberg LG; Ström H; Tekavec E; Tropé C; Bekassy Z
Ann Chir Gynaecol; 1979; 68(4):127-9. PubMed ID: 533219
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
[TBL] [Abstract][Full Text] [Related]
4. Endocervical glandular atypia in Papanicolaou smears.
Goff BA; Atanasoff P; Brown E; Muntz HG; Bell DA; Rice LW
Obstet Gynecol; 1992 Jan; 79(1):101-4. PubMed ID: 1727566
[TBL] [Abstract][Full Text] [Related]
5. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
6. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
[TBL] [Abstract][Full Text] [Related]
7. Atypical squamous cells in Papanicolaou smears.
Davis GL; Hernandez E; Davis JL; Miyazawa K
Obstet Gynecol; 1987 Jan; 69(1):43-6. PubMed ID: 3540762
[TBL] [Abstract][Full Text] [Related]
8. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
9. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
[TBL] [Abstract][Full Text] [Related]
10. False-positive squamous cell carcinoma in cervical smears: cytologic-histologic correlation in 19 cases.
Levine PH; Elgert PA; Mittal K
Diagn Cytopathol; 2003 Jan; 28(1):23-7. PubMed ID: 12508178
[TBL] [Abstract][Full Text] [Related]
11. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
12. [Follow-up of non-negative cervical cytological smears in the county of Funen].
Dahl MB; Hølund B; Sørensen B; Ahrons S; Grinsted P; Poulsen EF
Ugeskr Laeger; 1998 Sep; 160(40):5798-801. PubMed ID: 9782760
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the appropriate frequency of the cervical cancer screening (author's transl)].
Hando T; Kodama S; Obata N; Goto A; Takeuchi S; Aoki S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Aug; 33(8):1205-8. PubMed ID: 7276648
[TBL] [Abstract][Full Text] [Related]
14. Optimal frequency of screening for cervical cancer: a Toronto case-control study.
Clarke EA; Hilditch S; Anderson TW
IARC Sci Publ; 1986; (76):125-31. PubMed ID: 3570399
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of cervical neoplasia.
La Vecchia C
Biomed Pharmacother; 1985; 39(8):426-33. PubMed ID: 3841750
[TBL] [Abstract][Full Text] [Related]
16. DNA-cytometric diagnosis of prospective malignancy in borderline lesions of the uterine cervix.
Böcking A; Hilgarth M; Auffermann W; Hack-Werdier C; Fischer-Becker D; von Kalkreuth G
Acta Cytol; 1986; 30(6):608-15. PubMed ID: 3466496
[TBL] [Abstract][Full Text] [Related]
17. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
18. The influence of sample takers on the cellular composition of cervical smears.
Vooijs GP; Elias A; van der Graaf Y; Poelen-van de Berg M
Acta Cytol; 1986; 30(3):251-7. PubMed ID: 3459325
[TBL] [Abstract][Full Text] [Related]
19. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening.
Kennedy AW; Salmieri SS; Wirth SL; Biscotti CV; Tuason LJ; Travarca MJ
Gynecol Oncol; 1996 Oct; 63(1):14-8. PubMed ID: 8898161
[TBL] [Abstract][Full Text] [Related]
20. Cytological screening history of patients with early invasive cervical cancer.
Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
